Euroasian journal of hepato-gastroenterology

Register      Login

VOLUME 7 , ISSUE 2 ( July-December, 2017 ) > List of Articles


Viral Hepatitis in South Korea

Stella C Pak, Yaseen Alastal, Zubair Khan, Umar Darr

Citation Information : Pak SC, Alastal Y, Khan Z, Darr U. Viral Hepatitis in South Korea. Euroasian J Hepatogastroenterol 2017; 7 (2):163-165.

DOI: 10.5005/jp-journals-10018-1240

License: CC BY 3.0

Published Online: 01-12-2016

Copyright Statement:  Copyright © 2017; The Author(s).


How to cite this article

Pak SC, Alastal Y, Khan Z, Darr U. Viral Hepatitis in South Korea. Euroasian J Hepato-Gastroenterol 2017;7(2):163-165.

  1. The Economic Burden of Hepatitis A, B, and C in South Korea. Jpn J Infect Dis 2016 Jan;69(1):18-27.
  2. The costs of hepatitis A infections in South Korea. Epidemiol Health 2014 Aug;36:e2014011.
  3. Trends in disease and complications of hepatitis A virus infection in the United States, 1999-2011: a new concern for adults. J Infect Dis 2015 Jul;212(2):176-182.
  4. Age-period-cohort analysis of hepatitis A incidence rates in Korea from 2002 to 2012. Epidemiol Health 2016 Sep;38:e2016040.
  5. Hepatitis A in Korea from 2011 to 2013: current epidemiologic status and regional distribution. J Korean Med Sci 2016 Jan;31(1):67-72.
  6. Nationwide seropositivity of Hepatitis A in republic of Korea from 2005 to 2014, before and after the outbreak peak in 2009. PLoS One 2017 Jan;12:e0170432.
  7. Recent trends in hepatitis B virus infection in the general Korean population. Korean J Intern Med 2013 Jul;28(4):413-419.
  8. Clin Mol Hepatol 2004 Sep;10(3):191-196.
  9. Hepatitis B virus infection in South Korea: three decades after universal vaccination. Korean J Intern Med 2013 Jul;28(4):408-409.
  10. Current status of hepatitis C virus infection in Korea. Intervirology 2006;49(1-2):70-75.
  11. Viral hepatitis and liver cancer in Korea: an epidemiological perspective. Asian Pac J Cancer Prev 2013 Nov;14(11):6227-6231.
  12. The clinical outcomes of chronic hepatitis C in South Korea: a prospective, multicenter cohort study. Medicine (Baltimore) 2016 Aug;95(35):e4594.
  13. Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study. J Med Virol 2013 Oct;85(10):1724-1733.
  14. Final report of unmet needs of interferon-based therapy for chronic hepatitis C in Korea: basis for moving into the direct-acting antiviral era. Gut Liver 2017 Jul;11(4):543-550.
  15. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006 Apr;3(2):47-52.
  16. Thyroid stimulating hormone reference range and prevalence of thyroid dysfunction in the Korean population: Korea National Health and Nutrition Examination Survey 2013 to 2015. Endocrinol Metab (Seoul) 2017 Mar;32(1):106-114.
  17. The incidence and prevalence of diabetes mellitus and related atherosclerotic complications in Korea: a National Health Insurance Database Study. PLoS One 2014 Oct;9(10):e110650.
  18. Management of adverse events during the treatment of chronic hepatitis C infection. Clin Liver Dis (Hoboken) 2012 Apr;1(2):54-57.
  19. Review of boceprevir and telaprevir for the treatment of chronic hepatitis C. Can J Gastroenterol 2012 Apr;26(4):205-210.
  20. Interferon-free, direct-acting antiviral therapy for chronic hepatitis C. J Viral Hepat 2015 Nov;22(11):861-870.
  21. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea. J Med Virol 2011 Jul;83(7):1172-1177.
  22. Hepatitis D: scenario in the Asia-Pacific region. World J Gastroenterol 2010 Feb;16(5):554-562.
  23. Current status of hepatitis e virus infection in Korea. Gut Liver 2011 Dec;5(4):427-431.
  24. Epidemiology of hepatitis E in Northeastern China, South Korea and Japan. J Infect 2009 Mar;58(3):232-237.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.